Glenmark's generic Vagifem gets FDA approval
Glenmark Pharmaceuticals has received the Food and Drug Administration’s green light for estradiol vaginal inserts, 10 mcg.
The product is a generic version of Novo Nordisk’s Vagifem, 10 mcg.
Estradiol vaginal inserts had a market value of approximately $286.3 million for the 12 month period ending July 2018, according to IQVIA.
The product is a generic version of Novo Nordisk’s Vagifem, 10 mcg.
Estradiol vaginal inserts had a market value of approximately $286.3 million for the 12 month period ending July 2018, according to IQVIA.